Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2019 · 10-Q
Revenue$78.10M$78.10M+7.0% vs Q2 2018 Net Income$39.98M$39.98M+5.7% vs Q2 2018 EPS Diluted$0.92$0.92+1.1% vs Q2 2018 Operating Income$39,978,000+5.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin51.2%−0.7 pt vs Q2 2018
Net margin51.2%−0.7 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 8, 2019 · 39 d after period end